Cargando…

Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome

Sepsis refers to the systemic inflammatory response syndrome caused by infection. It is a major clinical problem and cause of death for patients in intensive care units worldwide. The Fat mass and obesity-related protein (FTO) is the primary N (6)-methyladenosine demethylase. However, the role of FT...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Jiahui, Wang, Faxi, Sun, Fei, Yue, Tiantian, Zhou, Qing, Yang, Chunliang, Rong, Shanjie, Yang, Ping, Xiong, Fei, Yu, Qilin, Zhang, Shu, Wang, Cong-Yi, Li, Jinxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128997/
https://www.ncbi.nlm.nih.gov/pubmed/34017338
http://dx.doi.org/10.3389/fimmu.2021.663295
Descripción
Sumario:Sepsis refers to the systemic inflammatory response syndrome caused by infection. It is a major clinical problem and cause of death for patients in intensive care units worldwide. The Fat mass and obesity-related protein (FTO) is the primary N (6)-methyladenosine demethylase. However, the role of FTO in the pathogenesis of inflammatory diseases remains unclear. We herein show that nanoparticle-mediated Fto-siRNA delivery or FTO inhibitor entacapone administration dramatically inhibited macrophage activation, reduced the tissue damage and improved survival in a mouse model of LPS-induced endotoxic shock. Importantly, ablation of FTO could inhibit NLRP3 inflammasome through FoxO1/NF-κB signaling in macrophages. In conclusion, FTO is involved in inflammatory response of LPS-induced septic shock and inhibition of FTO is promising for the treatment of septic shock.